
### [MONDO:0017341](http://purl.obolibrary.org/obo/MONDO_0017341)
**Label:** rare virus associated tumor

**Subclasses:** [MONDO:0015157](http://purl.obolibrary.org/obo/MONDO_0015157) (human herpesvirus 8-related disorder), [MONDO:0020328](http://purl.obolibrary.org/obo/MONDO_0020328) (classic Hodgkin lymphoma, mixed cellularity type), [MONDO:0020329](http://purl.obolibrary.org/obo/MONDO_0020329) (classic Hodgkin lymphoma, lymphocyte-rich type), [MONDO:0018842](http://purl.obolibrary.org/obo/MONDO_0018842) (primary effusion lymphoma), [MONDO:0018224](http://purl.obolibrary.org/obo/MONDO_0018224) (hydroa vacciniforme-like lymphoma), [MONDO:0019478](http://purl.obolibrary.org/obo/MONDO_0019478) (nodular lymphocyte predominant Hodgkin lymphoma), [MONDO:0019753](http://purl.obolibrary.org/obo/MONDO_0019753) (localized Castleman disease), [MONDO:0018049](http://purl.obolibrary.org/obo/MONDO_0018049) (Kaposi sarcoma), [MONDO:0019754](http://purl.obolibrary.org/obo/MONDO_0019754) (multicentric Castleman disease), [MONDO:0008067](http://purl.obolibrary.org/obo/MONDO_0008067) (nasopharyngeal carcinoma, susceptibility to, 2), [MONDO:0018223](http://purl.obolibrary.org/obo/MONDO_0018223) (systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood), [MONDO:0019752](http://purl.obolibrary.org/obo/MONDO_0019752) (pediatric Castleman disease), [MONDO:0019210](http://purl.obolibrary.org/obo/MONDO_0019210) (cutaneous neuroendocrine carcinoma), [MONDO:0019472](http://purl.obolibrary.org/obo/MONDO_0019472) (extranodal nasal NK/T cell lymphoma), [MONDO:0019471](http://purl.obolibrary.org/obo/MONDO_0019471) (adult T-cell leukemia/lymphoma), [MONDO:0020327](http://purl.obolibrary.org/obo/MONDO_0020327) (classic Hodgkin lymphoma, nodular sclerosis type), [MONDO:0007845](http://purl.obolibrary.org/obo/MONDO_0007845) (Kaposi sarcoma, susceptibility to), [MONDO:0004952](http://purl.obolibrary.org/obo/MONDO_0004952) (Hodgkins lymphoma), [MONDO:0005764](http://purl.obolibrary.org/obo/MONDO_0005764) (follicular dendritic cell sarcoma), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0011775](http://purl.obolibrary.org/obo/MONDO_0011775) (nasopharyngeal carcinoma), [MONDO:0014902](http://purl.obolibrary.org/obo/MONDO_0014902) (nasopharyngeal carcinoma, susceptibility to, 3; NPCA3), [MONDO:0010762](http://purl.obolibrary.org/obo/MONDO_0010762) (lymphoma, Hodgkin, Y-linked pseudoautosomal), [MONDO:0015459](http://purl.obolibrary.org/obo/MONDO_0015459) (nasopharynx carcinoma), [MONDO:0018628](http://purl.obolibrary.org/obo/MONDO_0018628) (HIV-associated cancer), [MONDO:0017347](http://purl.obolibrary.org/obo/MONDO_0017347) (Plasmablastic lymphoma), [MONDO:0017346](http://purl.obolibrary.org/obo/MONDO_0017346) (Epstein-Barr virus-positive diffuse large b-cell lymphoma of the elderly), [MONDO:0015564](http://purl.obolibrary.org/obo/MONDO_0015564) (Castleman disease), [MONDO:0017349](http://purl.obolibrary.org/obo/MONDO_0017349) (Myopericytoma), [MONDO:0018732](http://purl.obolibrary.org/obo/MONDO_0018732) (primary central nervous system lymphoma), [MONDO:0017348](http://purl.obolibrary.org/obo/MONDO_0017348) (lymphoepithelial-like carcinoma), [MONDO:0017601](http://purl.obolibrary.org/obo/MONDO_0017601) (diffuse large b-cell lymphoma with chronic inflammation), [MONDO:0017343](http://purl.obolibrary.org/obo/MONDO_0017343) (Epstein-Barr virus-associated malignant lymphoproliferative disorder), [MONDO:0017342](http://purl.obolibrary.org/obo/MONDO_0017342) (Epstein-Barr virus-related tumor), [MONDO:0010273](http://purl.obolibrary.org/obo/MONDO_0010273) (lymphoma, Hodgkin, X-linked pseudoautosomal), [MONDO:0017345](http://purl.obolibrary.org/obo/MONDO_0017345) (Epstein-Barr virus-associated mesenchymal tumor), [MONDO:0017784](http://purl.obolibrary.org/obo/MONDO_0017784) (Epstein-Barr virus-associated gastric carcinoma), [MONDO:0019466](http://purl.obolibrary.org/obo/MONDO_0019466) (lymphomatoid granulomatosis), [MONDO:0017344](http://purl.obolibrary.org/obo/MONDO_0017344) (Epstein-Barr virus-associated carcinoma), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), [MONDO:0019088](http://purl.obolibrary.org/obo/MONDO_0019088) (Post-transplant lymphoproliferative disease), [MONDO:0009348](http://purl.obolibrary.org/obo/MONDO_0009348) (classic Hodgkin lymphoma), [MONDO:0005058](http://purl.obolibrary.org/obo/MONDO_0005058) (leiomyosarcoma), [MONDO:0020330](http://purl.obolibrary.org/obo/MONDO_0020330) (classic Hodgkin lymphoma, lymphocyte-depleted type), 

**Corr. equiv. classes:** [Orphanet:300888](http://www.orpha.net/ORDO/Orphanet_300888), [Orphanet:86879](http://www.orpha.net/ORDO/Orphanet_86879), [OMIM:300221](http://purl.obolibrary.org/obo/OMIM_300221), [Orphanet:364033](http://www.orpha.net/ORDO/Orphanet_364033), [Orphanet:48686](http://www.orpha.net/ORDO/Orphanet_48686), [Orphanet:289685](http://www.orpha.net/ORDO/Orphanet_289685), [Orphanet:86875](http://www.orpha.net/ORDO/Orphanet_86875), [Orphanet:289666](http://www.orpha.net/ORDO/Orphanet_289666), [Orphanet:160](http://www.orpha.net/ORDO/Orphanet_160), [Orphanet:289644](http://www.orpha.net/ORDO/Orphanet_289644), [Orphanet:289682](http://www.orpha.net/ORDO/Orphanet_289682), [Orphanet:364039](http://www.orpha.net/ORDO/Orphanet_364039), [Orphanet:86893](http://www.orpha.net/ORDO/Orphanet_86893), [Orphanet:289661](http://www.orpha.net/ORDO/Orphanet_289661), [Orphanet:64720](http://www.orpha.net/ORDO/Orphanet_64720), [OMIM:613488](http://purl.obolibrary.org/obo/OMIM_613488), [Orphanet:70568](http://www.orpha.net/ORDO/Orphanet_70568), [Orphanet:33276](http://www.orpha.net/ORDO/Orphanet_33276), [Orphanet:93682](http://www.orpha.net/ORDO/Orphanet_93682), [Orphanet:313920](http://www.orpha.net/ORDO/Orphanet_313920), [Orphanet:93686](http://www.orpha.net/ORDO/Orphanet_93686), [Orphanet:93685](http://www.orpha.net/ORDO/Orphanet_93685), [Orphanet:289638](http://www.orpha.net/ORDO/Orphanet_289638), [OMIM:161550](http://purl.obolibrary.org/obo/OMIM_161550), [Orphanet:86902](http://www.orpha.net/ORDO/Orphanet_86902), [Orphanet:86869](http://www.orpha.net/ORDO/Orphanet_86869), [Orphanet:150](http://www.orpha.net/ORDO/Orphanet_150), [Orphanet:98293](http://www.orpha.net/ORDO/Orphanet_98293), [Orphanet:289656](http://www.orpha.net/ORDO/Orphanet_289656), [OMIM:607107](http://purl.obolibrary.org/obo/OMIM_607107), [Orphanet:102024](http://www.orpha.net/ORDO/Orphanet_102024), [Orphanet:443291](http://www.orpha.net/ORDO/Orphanet_443291), [OMIM:617075](http://purl.obolibrary.org/obo/OMIM_617075), [Orphanet:46135](http://www.orpha.net/ORDO/Orphanet_46135), [Orphanet:391](http://www.orpha.net/ORDO/Orphanet_391), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [Orphanet:289651](http://www.orpha.net/ORDO/Orphanet_289651), [OMIM:148000](http://purl.obolibrary.org/obo/OMIM_148000), [Orphanet:79140](http://www.orpha.net/ORDO/Orphanet_79140), [Orphanet:98843](http://www.orpha.net/ORDO/Orphanet_98843), [Orphanet:98844](http://www.orpha.net/ORDO/Orphanet_98844), [Orphanet:98845](http://www.orpha.net/ORDO/Orphanet_98845), [Orphanet:98846](http://www.orpha.net/ORDO/Orphanet_98846), [OMIM:400021](http://purl.obolibrary.org/obo/OMIM_400021), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [OMIM:236000](http://purl.obolibrary.org/obo/OMIM_236000), 

**Class expressions from DL-Learner:**

- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000023](http://purl.obolibrary.org/obo/HP_0000023) (Inguinal hernia))) 18.74%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 18.68%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 18.64%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 18.64%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 18.64%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000021](http://purl.obolibrary.org/obo/HP_0000021) (Megacystis))) 18.63%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000019](http://purl.obolibrary.org/obo/HP_0000019) (Urinary hesitancy))) 18.63%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 18.63%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 18.63%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 18.63%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 18.63%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 18.63%
- Thing 15.96%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 15.96%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 14.81%


